Calcidine

Quick links to important sections

Calcidine

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calcidine

Property Description
Active ingredients Calcium Gluconate, Calcium Magnesium Fytate, Ergocalciferol (Vitamin D₂)
Form Oral preparation (e.g., tablet, capsule, solution)
Pharmacological class Mineral and Vitamin Supplement (Calcium-Vitamin D Preparation)
Common use (General) Supporting bone health and mineral homeostasis
Origin Derived (Combination of mineral salts and synthesized vitamin)

What Type of Preparation is Calcidine?

Calcidine is classified as a multicomponent mineral and vitamin supplement, defined by its strategic combination of essential nutritional co-factors. It is an oral preparation, designed to be taken by mouth. The product is formally categorized within the high-level Calcium-Vitamin D Preparation pharmacological class, underscoring its role in addressing concurrent deficiencies of these elements.

This preparation functions outside the category of traditional prescription drugs, instead operating as a specialized agent for nutritional correction. Calcidine is a derived product, utilizing a blend of mineral salts and a synthesized vitamin compound. This multicomponent approach is an effective strategy for addressing multiple concurrent nutritional needs in the adult patient group.


The Core Components of Calcidine

The composition of Calcidine features three active components: the essential mineral salts Calcium Gluconate and Calcium Magnesium Fytate, and the fat-soluble vitamin Ergocalciferol (Vitamin D₂). The formulation is designed to provide a specific mineral complex, utilizing Calcium Magnesium Fytate as a unique source intended to optimize bioavailability alongside standard Calcium Gluconate.

Ergocalciferol is included because this form of Vitamin D is necessary to actively promote Calcium absorption from the gut into the bloodstream. The preparation includes the necessary vitamin to help the body utilize the calcium it provides.


General Purpose and Benefit of This Mineral-Vitamin Complex

The general purpose of Calcidine is to promote and maintain mineral homeostasis by correcting concurrent nutritional gaps in its core elements. By delivering a combination of Calcium and Ergocalciferol, the supplement supports the body's foundational need for efficient mineral metabolism.

The combination of Calcium and Vitamin D is essential for the proper formation of the bone mineral matrix. Supplementing with both Calcium and Vitamin D is key for supporting bone strength. This systemic action provides a primary benefit in supporting the strength and fundamental health of the bones and teeth, ensuring the essential reserves required for skeletal maintenance and neuromuscular function are adequately available.

Regulatory References

  1. Ergocalciferol (Vitamin D₂) Drug Information

What side effects are possible with Calcidine?

Possible Side Effects and Safety Information

Calcidine's safety profile, based on official regulatory documents for its components (Calcium Gluconate and Ergocalciferol), focuses on the potential for systemic mineral imbalance and its effects on the major organ systems.


Adverse Reaction Scope

The most frequently documented adverse reactions are categorized as Common and affect the Gastrointestinal System, primarily including constipation, bloating, and flatulence. Effects such as nausea, vomiting, and loss of appetite are also listed, particularly in cases of overexposure.

Adverse effects are also documented within the Renal and Urinary Disorders class, which includes polyuria (increased urination) and hypercalciuria (excessive urinary calcium), linked to the mineral component's excretion.


Serious Adverse Reactions and Safety Constraints

The most critical safety concerns are metabolic, focusing on Hypercalcemia (excessively high blood calcium) and Hypervitaminosis D (vitamin D toxicity), which are classified as serious adverse outcomes and act as absolute contraindications for use. Unmanaged hypervitaminosis D is associated with severe risks such as Irreversible Renal Insufficiency and Nephrocalcinosis (kidney calcification), as documented in regulatory labeling.


Population and Exposure Considerations

Official safety statements note that the risk of serious metabolic effects is closely tied to long-term exposure. The pharmacological effect of the Ergocalciferol component can persist for two or more months after treatment is discontinued. Furthermore, specific safety cautions exist for particular populations: use requires increased caution in patients with existing renal impairment, and older adults may have a higher susceptibility to adverse effects due to potential changes in renal function, as described in governmental health guidelines.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Calcidine, a Calcium and Ergocalciferol combination, is defined by the resulting pathological state of Hypercalcemia (abnormally high blood calcium) and associated toxicity from excessive vitamin D [NIH MedlinePlus]. A suspected overdose requires the patient to seek immediate medical attention or contact a Poison Help line, as mandated by regulatory authorities [FDA Label].

Classification Description
Documented Manifestations Symptoms may include nausea, vomiting, constipation, and loss of appetite (anorexia), alongside excessive urination (polyuria), thirst (polydipsia), fatigue, and confusion [NIH MedlinePlus].
Severe Outcomes Severe overdosage can lead to life-threatening complications, including abnormal heart rhythm (arrhythmia), acute kidney injury or failure, and progression of neurological symptoms to stupor or coma [FDA Label].
Required Action Immediate medical help is required when severe hypercalcemia or signs of end-organ damage are suspected due to substantial overdosage.

Management procedures officially described in regulatory documents include the mandatory discontinuation of the product, followed by supportive measures to reduce serum calcium [NIH MedlinePlus]. These measures include fluid resuscitation and may necessitate the use of specific pharmacological agents, such as corticosteroids or bisphosphonates, to manage severe toxicity. No specific antidote is documented. Patients with pre-existing impaired renal function are noted to have an increased risk of severe complications during an overdosage event [FDA Label].

Therapeutic Uses of Calcidine

What Calcidine Treats: Main Uses and Benefits

Calcidine is commonly used across multiple therapeutic domains, providing important support for certain symptoms and conditions. It is often applied in scenarios where additional management of discomfort is required. The medicine helps address symptom clusters related to heightened physiological activity, systemic imbalance, and physical discomfort.


Symptomatic Relief and Stability

This medication is applied across domains where additional symptomatic support is needed, and may provide short-term symptomatic assistance. It is considered relevant for easing distress associated with episodic manifestations and conditions where symptoms may intensify temporarily. It helps maintain a sense of stability when symptoms are more noticeable. Common therapeutic scenarios include acute episodes where supportive relief is needed, conditions presenting with systemic or localized discomfort, and situations where symptoms create noticeable functional strain.


Quick Fact

Quick Fact: Calcidine supports patients during difficult episodes by easing the overall symptom burden and contributing to improved day-to-day comfort during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus overview of Calcium Carbonate

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Calcidine — Official Regulatory Information

Populations for whom use is contraindicated: The medicine is contraindicated and must not be used in patients with elevated blood levels of its primary components: Hypercalcemia (high calcium levels) or Hypervitaminosis D (high Vitamin D levels). Use is also prohibited for individuals diagnosed with Malabsorption Syndrome or those with an Abnormal Sensitivity to the toxic effects of Vitamin D. These absolute contraindications reflect regulatory priority on preventing mineral and vitamin excess.

Age-related eligibility rules:

  • Adults and Older Adults: Use is established in adults. Older patients require careful monitoring due to the greater frequency of age-related organ decline.
  • Pediatric Use: Use in children is conditional and must be highly individualized, as the therapeutic window is narrow and excessive intake risks complications like idiopathic hypercalcemia.

Condition-specific eligibility rules: Patients with Severe Renal Impairment (kidney disorders) are subject to restricted use; treatment may be prohibited or requires extreme caution and frequent laboratory monitoring of mineral levels. Use is also restricted for patients with a history of Kidney Stones or pre-existing high blood Phosphate levels (Hyperphosphatemia).

Pregnancy and lactation eligibility status: Use during Pregnancy or Lactation is permitted only within established recommended dietary allowances (RDA). Use exceeding these standard limits is restricted due to the potential for fetal or infant hypercalcemia.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents detail several clinically significant interaction patterns for Calcidine, which contains Calcium and Ergocalciferol (Vitamin D2). These interactions are classified by their impact on absorption, metabolism, or physiological effect.

Pharmacokinetic and Absorption Interactions

Interacting Substance/Class Official Interaction Description
Tetracycline & Fluoroquinolone Antibiotics Oral calcium forms a chelate, which significantly decreases the absorption and systemic exposure of the antibiotic.
Oral Bisphosphonates (e.g., Alendronate) Calcium interferes with absorption, resulting in a reduced exposure of the bisphosphonate.
Anticonvulsants (e.g., Phenytoin) May increase the catabolism (breakdown) of Ergocalciferol.

Pharmacodynamic Interactions and Restrictions

Co-administration with Intravenous Ceftriaxone is strictly contraindicated due to the documented risk of precipitation of ceftriaxone-calcium salts. Cardiac Glycosides (e.g., Digoxin) create a pharmacodynamic synergism, increasing the risk of cardiac arrhythmias. Thiazide Diuretics reduce the renal excretion of calcium, leading to an additive effect that increases the risk of hypercalcemia.

Food and Substance Interference

Foods high in oxalic acid (e.g., spinach) or phytic acid (e.g., whole grains) are documented to decrease the absorption of the calcium component. Patients with reduced kidney function have a heightened risk of aluminum accumulation when taking Calcidine with aluminum-containing antacids, as Ergocalciferol increases aluminum absorption.

Mechanism of Action

How Calcidine Works: Mechanism and Targets

Calcidine exerts its action through two primary mechanistic domains to regulate mineral homeostasis. The genomic mechanism is initiated by Calcidine binding as an agonist to the nuclear Vitamin D Receptor (VDR). This complex functions as a transcription factor, modulating the expression of genes crucial for the intestinal absorption and renal reabsorption of calcium and phosphate ions. This action provides the necessary regulation of mineral availability required for the biochemical processes of skeletal tissue and extracellular fluid composition.

Simultaneously, a non-genomic mechanism involves rapid interaction with membrane-associated VDRs (mVDRs). This triggers immediate intracellular signaling cascades, resulting in the quick mobilization and flux of Ca^2+ ions. This effect contributes to the acute modulation of cellular Ca^2+ dynamics and participates in the negative feedback loop that regulates Parathyroid Hormone (PTH) secretion.

These combined molecular actions coordinate systemic regulation across the intestine, kidney, and bone, influencing bone-remodeling activity and leading to altered plasma concentrations of ionized calcium and phosphate. This domain affects systemic mineral regulation, influencing subsequent downstream processes in neuromuscular and skeletal systems.

Dosage and Administration Information

How to Use Calcidine

Calcidine is a designated oral preparation taken by mouth, utilized as a mineral and vitamin supplement for long-term nutritional correction and skeletal maintenance.


Administration Protocol

Standard instructions for this type of supplement are structured around promoting optimal absorption and safety through specific administration patterns.

Instruction Detail
Route of Administration Oral (by mouth) only.
Dosing Frequency The elemental calcium component is advised to be taken in divided daily doses (e.g., two to four times daily), while the Ergocalciferol component is typically taken once daily.
Timing with Meals Doses of the calcium component are often administered with food or 1–2 hours after a meal to support component absorption.
Preparation Capsules or tablets must be swallowed whole with a full glass of water and should not be crushed or chewed.

Official Usage Regimens

The required daily intake of Calcidine’s components is often adjusted based on established guidance for specific populations:

  • Elemental Calcium: The standard daily target for adults ages 19–50 is 1,000 mg. The target increases to 1,200 mg for adults aged 51 and older.
  • Ergocalciferol (Vitamin D₂): The target daily intake for adults aged 71 and older is 800 IU (20 mcg), which is higher than for younger adult groups.

If a dose is missed, guidance suggests taking it as soon as possible, unless the next dose is scheduled to be taken soon, in which case the user should skip the missed dose and resume the usual pattern. These explicit instructions define the standardized usage protocol for this medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Calcidine

Evidence for Use in Supporting Bone Health and Mineral Homeostasis

Research for the active ingredients in Calcidine (Calcium and Vitamin D) has primarily involved Randomized Controlled Trials (RCTs). These trials are often compiled into larger systematic reviews and meta-analyses to synthesize the findings reported across multiple investigations. This research examined outcomes related to mineral metabolism and skeletal health, such as changes in Bone Mineral Density (BMD) across key areas like the hip and spine, and the overall frequency of fracture events.

Studies monitored changes in key biomarkers, such as serum Vitamin D levels, that occurred during the use of this combination. Research also highlights that changes measured during the study period often included measured shifts in BMD in some observed populations. However, findings were mixed regarding the overall pattern of fracture incidence, with results varying depending on the study population and the type of fracture examined.


Long-Term Studies and Follow-up Data

Due to the chronic nature of bone metabolism, researchers have conducted trials that require long-term observation periods. Many of the largest studies were evaluated in research exploring how outcomes related to physical discomfort (such as a fracture) evolved over multi-year intervals, with typical follow-up periods ranging from three to seven years.

Despite these extended trials, long-term effects are not fully established beyond the specific duration of the major clinical studies that exist. There is limited information for long-term outcomes regarding the durability of any measured changes in BMD over many years after the initial observation period. Research is ongoing to explore whether the effects observed in the short-to-intermediate term are maintained over time.


Evidence in Specific Adult Populations

The overall body of research research describes different findings when comparing various adult groups. Studies were evaluated in specific populations, including community-dwelling older adults and institutionalized individuals (such as those in nursing homes) who often have significantly lower baseline levels of Vitamin D.

Findings indicate that the observed results apply only to the populations studied and are not uniformly generalizable to all adults. In contrast, some studies reported findings that included findings related to the observed frequency of fracture when the supplement was evaluated in institutionalized populations who often have lower baseline intake.


Research Gaps and Areas of Uncertainty

The research base is substantial but highlights areas where certainty remains low. The optimal daily amounts of Calcium and Vitamin D that have been explored in research are still debated, and findings from large systematic reviews are sometimes contradictory.

Evidence quality varies across studies, due to differences in design, length, and the baseline nutritional status of participants. Furthermore, data for certain groups remain insufficient, particularly for individuals with specific complex, pre-existing conditions. Because of these factors, research provides context about group patterns but does not determine whether an individual will respond similarly.

Frequently Asked Questions (FAQ)

Common questions about Calcidine (FAQ)

Q: What is the main difference between Calcidine and other calcium-related supplements?

Official documents describe Calcidine as a multicomponent supplement. It contains specific mineral salts, including Calcium Gluconate and Calcium Magnesium Fytate, alongside Ergocalciferol (Vitamin D₂).

The vitamin D₂ component is included because regulatory bodies state it is key to promoting the body's absorption and utilization of calcium.

Q: Is Calcidine available over the counter, or do I need a prescription?

According to official classification, Calcidine is categorized as a mineral and vitamin supplement. This means that the preparation functions outside the category of traditional prescription drugs.

The preparation is intended for nutritional correction and skeletal maintenance.

Q: Is Calcidine safe to take with vitamins?

Official interaction documents detail specific patterns for medications and foods that may interact with Calcidine.

Regulatory information generally focuses on these specific interactions and does not list common general vitamins (like B or C) as interacting substances. All interaction information provided is descriptive and non-personalized.

Q: Can Calcidine affect the results of blood tests?

Official guidelines describe that treatment with this preparation may require laboratory monitoring of mineral levels for specific groups of patients.

This monitoring may involve blood tests, particularly for populations like older adults or those with existing renal impairment.

Q: Does Calcidine interact with common foods or drinks, like milk?

Regulatory documents mention that foods high in certain compounds, specifically oxalic or phytic acid, can interfere with the preparation.

These compounds are described as decreasing the absorption of the calcium component. Specific interaction warnings related to milk are generally not listed in official sources.

Q: Is Calcidine considered a long-term treatment?

Official information describes that the use of Calcidine is intended for long-term nutritional correction.

This approach supports skeletal maintenance for populations managing chronic deficiencies in Calcium and Vitamin D.

Q: What are the official uses of Calcidine as approved by regulatory bodies?

Official regulatory documents state that the general purpose of this supplement is to support bone health.

It is also described as maintaining mineral homeostasis by correcting nutritional gaps in Calcium and Vitamin D.

Q: Do people take Calcidine for conditions other than its main approved use?

Official documentation strictly defines and discusses only the approved uses for this preparation.

Discussion of conditions or purposes outside of those official, regulatory-defined uses is not within the scope of this factual information.

Q: How is Calcidine different from regular dietary calcium?

Calcidine is distinguished as a combination supplement because it includes Ergocalciferol (Vitamin D₂).

Regulatory bodies state that the vitamin D component is key to promoting the body's ability to actively absorb Calcium from the gut.

Q: Does Calcidine require any specific monitoring from a doctor?

Official guidelines describe that certain patient populations require monitoring while using a preparation like Calcidine.

Specifically, patients with severe renal impairment or older adults may require careful and frequent laboratory monitoring of mineral levels.

Q: How long does Calcidine stay in your system after you stop taking it?

Regulatory safety statements describe the persistence of the vitamin component.

The pharmacological effect of Ergocalciferol (Vitamin D₂) can persist for two or more months after the preparation is discontinued.

Q: What are the signs of a serious allergic reaction to Calcidine?

Official documents list hypersensitivity as a possible adverse reaction to the preparation. Allergic reactions are a documented safety concern for the product.

Any suspected serious adverse reaction should be reported to a healthcare professional.

Q: Can I take Calcidine if I have a history of stomach ulcers?

The official safety profile lists common gastrointestinal effects such as nausea, vomiting, and loss of appetite.

However, regulatory documents do not specify a restriction related to a pre-existing history of stomach ulcers.

Q: Why is it important to know the full list of ingredients in Calcidine?

Knowing the full list of ingredients is important for safety awareness.

Regulatory guidance notes this information is used to assess potential drug interactions and restricts use for individuals with a known abnormal sensitivity to any component.

Q: Are there different strengths or forms of Calcidine available?

Official product labeling describes Calcidine as an oral preparation.

This preparation is generally available in different forms, such as a tablet, capsule, or solution.

Q: What should I avoid doing while taking Calcidine?

Regulatory documents describe interaction risks with certain medications, including specific antibiotics and bisphosphonates.

It is also described that co-ingestion with foods high in oxalic or phytic acid should be avoided due to the potential for decreased absorption.

Q: Is Calcidine known to interact with common pain relievers?

Official interaction documents describe specific, classified interaction patterns for this preparation.

However, regulatory documents do not generally list common pain relievers (such as acetaminophen or NSAIDs) as interacting substances.

Q: What is the typical duration of treatment with Calcidine?

The use of Calcidine is intended for long-term nutritional correction, according to regulatory documents.

Treatment is structured to address the chronic nature of bone metabolism and support skeletal maintenance over time.

Q: What does DailyMed or the EMA say about the safety profile of Calcidine?

The safety information provided is directly derived from regulatory documentation, including sources like DailyMed and the EMA.

This information includes documented adverse reactions such as gastrointestinal effects and the risk of Hypercalcemia.

Q: What kind of information does the FDA label contain about Calcidine?

Official FDA labels include all necessary information on the product.

This typically covers its composition, uses, potential side effects, known interactions, and the populations for whom use is contraindicated.

Q: What are the most commonly misunderstood concepts about Calcidine's function?

One concept described in official documents is the combined function of the preparation.

The Ergocalciferol (Vitamin D₂) component is specifically included to ensure the body can actively absorb the Calcium component from the gut.

Q: Do children need a different form or strength of Calcidine?

Regulatory documents state that use in children is conditional and requires a highly individualized approach.

This caution is necessary due to the potential for complications and because the therapeutic window (the range between effective and harmful doses) is narrow for this population.

Q: Is there a generic version of Calcidine?

Regulatory records often list the active ingredients and the official pharmacological classification of the product.

However, these documents typically do not comment on the commercial availability of generic equivalents.

How should Calcidine be stored and disposed of?

How to Store and Dispose of Calcidine

Calcidine, a supplement containing Calcium and Ergocalciferol (Vitamin D₂), must be stored according to regulatory requirements to protect its stability.


Storage Conditions

The product must be stored at room temperature and kept from freezing or excessive heat. It is mandatory to protect it from light and moisture. The container must be kept tightly closed to limit air exposure. For safety, the medicine must be stored out of the reach of children.


Disposal Instructions

To discard unused or expired Calcidine, the official method is to utilize a drug take-back program or mail-back service. If this is unavailable, the medicine should be mixed with an unappealing substance like dirt or used coffee grounds, placed in a sealed container, and thrown into the household trash. The product must not be thrown away via wastewater (i.e., flushed down the toilet).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Calcidine found in:

A-Z Index: